Learn about CVE-2018-14789 affecting Philips' IntelliSpace Cardiovascular products. Discover the impact, affected versions, and mitigation steps for this security vulnerability.
A vulnerability has been discovered in Philips' IntelliSpace Cardiovascular (ISCV) products, potentially allowing unauthorized code execution and privilege escalation.
Understanding CVE-2018-14789
This CVE involves an unquoted search path or element vulnerability in Philips' ISCV products.
What is CVE-2018-14789?
This vulnerability in Philips' IntelliSpace Cardiovascular (ISCV) products (versions 3.1 or earlier) and Xcelera (version 4.1 or earlier) could enable an attacker to execute arbitrary code and elevate their privilege level.
The Impact of CVE-2018-14789
The vulnerability could lead to unauthorized code execution and privilege escalation, posing a significant security risk to affected systems.
Technical Details of CVE-2018-14789
This section provides detailed technical information about the vulnerability.
Vulnerability Description
The vulnerability involves an unquoted search path or element in Philips' ISCV products, potentially allowing attackers to execute arbitrary code.
Affected Systems and Versions
Exploitation Mechanism
Attackers could exploit this vulnerability to execute arbitrary code and potentially escalate their privileges on the affected systems.
Mitigation and Prevention
Protecting systems from CVE-2018-14789 requires immediate actions and long-term security practices.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates